Sign in

CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Design Therapeutics, Inc.

Sign in to watch
Ticker
DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
823929248
Phone
858-293-4900
Business address
6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-30 Jeffries Sean Chief Operating Officer Purchase +3,050 $20.00 $61K 3,050
2021-03-30 Quan Venture Fund II, L.P. 10% owner Conversion +4,439,839 4,439,839
2021-03-30 Quan Venture Fund II, L.P. 10% owner Conversion +280,991 4,720,830
2021-03-30 Quan Venture Fund II, L.P. 10% owner Conversion · Series A Preferred Stock −7,236,938 0
2021-03-30 Quan Venture Fund II, L.P. 10% owner Conversion · Series B Preferred Stock −458,016 0
2021-03-30 SR One Capital Fund I Aggregator LP 10% owner Conversion +4,439,839 4,439,839
2021-03-30 SR One Capital Fund I Aggregator LP 10% owner Conversion +936,637 5,376,476
2021-03-30 SR One Capital Fund I Aggregator LP 10% owner Purchase +250,000 $20.00 $5.0M 5,626,476
2021-03-30 SR One Capital Fund I Aggregator LP 10% owner Conversion · Series A Preferred Stock −7,236,938 0
2021-03-30 SR One Capital Fund I Aggregator LP 10% owner Conversion · Series B Preferred Stock −1,526,718 0
2021-03-30 Xu Stella Director Conversion +4,439,839 4,439,839
2021-03-30 Xu Stella Director Conversion +280,991 4,720,830
2021-03-30 Xu Stella Director Purchase +10,000 $20.00 $200K 4,730,830
2021-03-30 Xu Stella Director Conversion · Series A Preferred Stock −7,236,938 0
2021-03-30 Xu Stella Director Conversion · Series B Preferred Stock −458,016 0
2021-03-30 George Simeon Director Conversion +4,439,839 4,439,839
2021-03-30 George Simeon Director Conversion +936,637 5,376,476
2021-03-30 George Simeon Director Purchase +250,000 $20.00 $5.0M 5,626,476
2021-03-30 George Simeon Director Conversion · Series A Preferred Stock −7,236,938 0
2021-03-30 George Simeon Director Conversion · Series B Preferred Stock −1,526,718 0

Page 6 of 7 · 135 trades